| Product ID |
Product Name |
CAS# |
Purity |
| Y3286295 |
HIF-2a agonist 2 |
2750141-15-0 |
99% |
| Y3297006 |
TASK-1-IN-1 |
600125-11-9 |
98% |
| Y3104769 |
CDK9-IN-13 |
2768712-71-4 |
99% |
| Y3307664 |
CB2R/FAAH modulator-3 |
2876918-67-9 |
99% |
| Y3268243 |
KHK-IN-3 |
2568608-48-8 |
99% |
| Y3306474 |
Bi-Mc-VC-PAB-MMAE |
1620837-70-8 |
99% |
| Y3248758 |
SJ10542 |
2789678-92-6 |
99.92% |
| Y3249184 |
RSS0680 |
2769753-48-0 |
98% |
| Y3265538 |
DS96432529 |
2871872-79-4 |
99% |
| Y3289672 |
S07-2010 |
1223194-71-5 |
99% |
| Y3268471 |
TP0472993 |
2126874-77-7 |
98% |
| Y3288207 |
NRP1 antagonist 1 |
2569598-01-0 |
99% |
| Y3296247 |
YAP-TEAD-IN-2 |
2714432-83-2 |
98% |
| Y3296875 |
NRX-0492 |
2416130-57-7 |
98% |
| Y3308135 |
Seconeolitsine |
2650074-56-7 |
95% |
| Y3268244 |
SV40 large T antigen NLS |
163815-24-5 |
98% |
| Y3261542 |
(R,R)-VVD-118313 |
2875046-31-2 |
99% |
| Y3307883 |
2-((3-Chlorobenzyl)(methyl)amino)-N-(chroman-4-yl)acetamide |
923720-58-5 |
95% |
| Y3288110 |
FSHR agonist 1 |
1256776-89-2 |
98% |
| Y3117804 |
4-Chloro-5-fluoro-2-methylbenzonitrile |
1807236-92-5 |
98% |
| Y3304602 |
S1R agonist 1 hydrochloride |
242487-82-7 |
99% |
| Y3290529 |
TEAD-IN-3 |
2416418-11-4 |
98% |
| Y3117772 |
(1R,2S,5R)-8-(tert-butoxycarbonyl)-8-azabicyclo[3.2.1]Octane-2-carboxylic acid |
2231664-84-7 |
97% |
| Y3270906 |
AGN 192870 |
166977-57-7 |
98% |
| Y3264337 |
Ladostigil hydrochloride |
209394-18-3 |
99% |
| Y3289196 |
PI3K/mTOR Inhibitor-11 |
2845104-25-6 |
98% |
| Y3297516 |
ACG416B |
795316-15-3 |
98% |
| Y3294969 |
PCSK9-IN-11 |
2882035-56-3 |
99% |
| Y3261538 |
D-Phenylalanine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-leucyl]-, phenylmethyl ester |
159549-97-0 |
95% |
| Y3270427 |
5-Bromo-7-fluoro-2,3-dihydrobenzofuran-3-amine |
1156991-76-2 |
95% |
| Y3308952 |
1-(4-Chloropyridin-2-yl)cyclopropane-1-carbonitrile |
1427012-83-6 |
95% |
| Y3289948 |
Mefatinib free base |
1639014-72-4 |
99% |
| Y3297784 |
6-Benzylaminopurine-d5 |
2322358-20-1 |
98% |
| Y3291086 |
MEL24 |
642072-48-8 |
98% |
| Y3292553 |
HIF-IN-1 |
2393928-76-0 |
99% |
| Y3305367 |
PIKfyve-IN-1 |
2857982-26-2 |
96% |
| Y3269925 |
Serine Hydrolase inhibitor-21 |
366448-34-2 |
99.71% |
| Y3294023 |
JHDM-IN-1 |
1310809-17-6 |
97% |
| Y3261578 |
Osivelotor |
2417955-18-9 |
99% |
| Y3289171 |
NS2B/NS3-IN-3 |
2832876-90-9 |
98% |
| Y3310471 |
CWI1-2 |
2408590-36-1 |
95% |
| Y3286328 |
NH2-PEG2-methyl acetate hydrochloride |
208647-73-8 |
95% |
| Y3260114 |
EGFR/HER2-IN-9 |
1637253-79-2 |
98.73% |
| Y3307006 |
PROTAC BRD4 degrader for PAC-1 |
2417370-39-7 |
99% |
| Y3296557 |
PKH 26 |
154214-55-8 |
95% |
| Y3255049 |
TDP1 Inhibitor-2 |
859142-95-3 |
99% |
| Y3255050 |
ALDH3A1-IN-1 |
1039855-56-5 |
95.0% |
| Y3261861 |
Mitochondria degrader-1 |
2241669-05-4 |
95% |
| Y3289523 |
FLT3-IN-17 |
2758999-62-9 |
99% |
| Y3268362 |
Dibenzocyclooctyne-Cy5.5 |
2643308-61-4 |
97.68% |
| Y3290567 |
KDM4-IN-3 |
1068515-53-6 |
99% |
| Y3258644 |
Antibacterial agent 125 |
1274611-43-6 |
98% |
| Y3297152 |
ZY-444 |
1802650-31-2 |
98% |
| Y3308237 |
STL1267 |
1429024-58-7 |
99% |
| Y3289657 |
(R)-Azasetron besylate |
2025360-91-0 |
98% |
| Y3266173 |
Vamotinib |
1416241-23-0 |
98.69% |
| Y3297129 |
Larotinib mesylate hydrate |
2097129-93-4 |
98% |
| Y3267055 |
(S,R,S)-AHPC-3-methylbutanyl acetate-methanesulfonothioate-PEG3-NH2 TFA |
2417370-48-8 |
99.42% |
| Y3297160 |
R-PSOP |
1185189-97-2 |
99% |
| Y3266994 |
Sec61-IN-3 |
2484862-54-4 |
98.08% |
| Y3269881 |
3-IN-PP1 |
2227110-54-3 |
95% |
| Y3266404 |
MG-2119 |
1065500-40-4 |
99% |
| Y3271994 |
4-(((Tert-butoxycarbonyl)amino)methyl)bicyclo[2.1.1]Hexane-1-carboxylic acid |
2108194-57-4 |
95% |
| Y3266999 |
Atinvicitinib |
2169273-59-8 |
98.03% |
| Y3271780 |
Dimethyl-F-OICR-9429-COOH |
2407458-49-3 |
98% |
| Y3291710 |
VSV-G tag Peptide |
103425-05-4 |
99% |
| Y3271658 |
3,4-Dibromo-Mal-PEG2-amine TFA |
2296708-07-9 |
98.0% |
| Y3113756 |
tert-Butyl (S)-3-(2-ethoxy-2-oxoethyl)piperazine-1-carboxylate |
2007920-22-9 |
97% |
| Y3292371 |
SMARCA-BD ligand 1 for Protac hydrochloride |
2380272-56-8 |
99% |
| Y3309783 |
ACA-28 |
948044-25-5 |
99% |
| Y3295949 |
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br |
2345733-40-4 |
99% |
| Y3271323 |
Amgen-23 |
1448706-15-7 |
99% |
| Y3270094 |
Resomelagon acetate |
1809420-72-1 |
99% |
| Y3267517 |
PAMP-12 unmodified |
929905-12-4 |
95% |
| Y3265592 |
hGPR91 antagonist 3 |
1314796-31-0 |
98.82% |
| Y3297947 |
Taplucainium chloride |
2489565-37-7 |
98% |
| Y3269856 |
Dovitinib-RIBOTAC |
2759351-68-1 |
98.93% |
| Y3267717 |
Deg-1 |
2761446-55-1 |
99% |
| Y3305416 |
(2a,3ß,4a)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid |
132282-70-3 |
98% |
| Y3266305 |
Sipagladenant |
858979-50-7 |
99.82% |
| Y3286904 |
(S,R,S)-AHPC-C10-NHBoc |
2412055-13-9 |
98% |
| Y3295531 |
Antibacterial agent 19 |
79660-59-6 |
99% |
| Y3286709 |
LP-184 |
924835-67-6 |
99% |
| Y3311501 |
Methyl 3-bromo-1H-thieno[3,2-c]pyrazole-5-carboxylate |
2020003-64-7 |
95% |
| Y3286540 |
PD-1/PD-L1-IN-13 |
2865841-81-0 |
99% |
| Y3265858 |
Ac32Az19 |
2760674-72-2 |
99.50% |
| Y3264170 |
2-Fluoro-3-phenylbicyclo[1.1.1]pentane-1-carboxylic acid |
2648962-09-6 |
95% |
| Y3305434 |
HIF-2a-IN-8 |
2734922-78-0 |
99% |
| Y3250731 |
Endothelin 1 (swine, human) TFA |
394693-38-0 |
99.95% |
| Y3289099 |
GLPG2534 |
2095615-97-5 |
98% |
| Y3290273 |
Glucocorticoid receptor agonist-1 Ala-Ala-Mal |
2166376-51-6 |
99% |
| Y3268242 |
Rac-(3ar,4s,9bs)-8-methyl-3h,3ah,4h,5h,9bh-cyclopenta[c]quinoline-4-carboxylic acid |
1212300-23-6 |
95% |
| Y3295893 |
TNG260 |
2935964-98-8 |
99% |
| Y3118045 |
4-(3-(Trifluoromethyl)-1h-pyrazol-1-yl)phenol |
1339680-51-1 |
98% |
| Y3258430 |
5A2-SC8 |
1857341-90-2 |
98% |
| Y3118041 |
RSH-7 |
2764609-97-2 |
98% |
| Y3295237 |
Succinate/succinate receptor antagonist 1 |
2361972-29-2 |
99% |
| Y3294241 |
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc |
1799711-31-1 |
95% |
| Y3292050 |
DLin-M-C4-DMA |
1226909-66-5 |
95%+ |
| Y3307710 |
MitoTracker Deep Red FM |
873315-86-7 |
95% |